{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T17:26:19Z","timestamp":1793813179833,"version":"4.6.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1016\/j.metabol.2008.11.009","type":"journal-article","created":{"date-parts":[[2009,4,17]],"date-time":"2009-04-17T04:28:47Z","timestamp":1239942527000},"page":"586-593","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["Incretin hormone secretion in women with polycystic ovary syndrome: roles of obesity, insulin sensitivity, and treatment with metformin"],"prefix":"10.1016","volume":"58","author":[{"given":"Pernille Fog","family":"Svendsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisbeth","family":"Nilas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sten","family":"Madsbad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens Juul","family":"Holst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2008.11.009_bib1","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1210\/jcem-24-10-1076","article-title":"Plasma insulin response to oral and intravenous glucose administration","volume":"24","author":"Elrick","year":"1964","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2008.11.009_bib2","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1210\/edrv-9-1-122","article-title":"Immunoreactive gastric inhibitory polypeptide","volume":"9","author":"Krarup","year":"1988","journal-title":"Endocr Rev"},{"key":"10.1016\/j.metabol.2008.11.009_bib3","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1001\/archinte.1969.00300130043007","article-title":"Entero-insular axis","volume":"123","author":"Unger","year":"1969","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.metabol.2008.11.009_bib4","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/BF01225454","article-title":"The incretin concept today","volume":"16","author":"Creutzfeldt","year":"1979","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2008.11.009_bib5","doi-asserted-by":"crossref","first-page":"4912","DOI":"10.1210\/jc.2005-0382","article-title":"Normal secretion and action of the gut incretin hormones glucagon-like peptide\u20131 and glucose-dependent insulinotropic polypeptide in young men with low birth weight","volume":"90","author":"Schou","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2008.11.009_bib6","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/BF02427280","article-title":"Reduced incretin effect in type 2 (non\u2013insulin-dependent) diabetes","volume":"29","author":"Nauck","year":"1986","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2008.11.009_bib7","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1468-1293.2005.00270.x","article-title":"Enhanced glucagon-like peptide\u20131 (GLP-1) response to oral glucose in glucose-intolerant HIV-infected patients on antiretroviral therapy","volume":"6","author":"Andersen","year":"2005","journal-title":"HIV Med"},{"key":"10.1016\/j.metabol.2008.11.009_bib8","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1530\/eje.0.1350425","article-title":"Gut incretin hormones in identical twins discordant for non\u2013insulin-dependent diabetes mellitus (NIDDM)\u2014evidence for decreased glucagon-like peptide 1 secretion during oral glucose ingestion in NIDDM twins","volume":"135","author":"Vaag","year":"1996","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.metabol.2008.11.009_bib9","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1007\/s001250051444","article-title":"Twenty-four-hour insulin secretion rates, circulating concentrations of fuel substrates and gut incretin hormones in healthy offspring of type II (non\u2013insulin-dependent) diabetic parents: evidence of several aberrations","volume":"42","author":"Nyholm","year":"1999","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2008.11.009_bib10","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1172\/JCI119628","article-title":"Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR)","volume":"100","author":"Ferrannini","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2008.11.009_bib11","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3109\/00365528009181538","article-title":"Gastric inhibitory polypeptide (GIP) and insulin release after small-bowel resection in man","volume":"15","author":"Lauritsen","year":"1980","journal-title":"Scand J Gastroenterol."},{"key":"10.1016\/j.metabol.2008.11.009_bib12","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1210\/jc.2002-021873","article-title":"Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus","volume":"88","author":"Vilsboll","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2008.11.009_bib13","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1210\/jcem-55-2-329","article-title":"Gastric inhibitory polypeptide release after oral glucose: relationship to glucose intolerance, diabetes mellitus, and obesity","volume":"55","author":"Salera","year":"1982","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2008.11.009_bib14","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1136\/gut.38.6.916","article-title":"Attenuated GLP-1 secretion in obesity: cause or consequence?","volume":"38","author":"Ranganath","year":"1996","journal-title":"Gut"},{"key":"10.1016\/j.metabol.2008.11.009_bib15","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1055\/s-2004-814222","article-title":"Glucagon-like peptide 1 (GLP-1) secretion and plasma dipeptidyl peptidase IV (DPP-IV) activity in morbidly obese patients undergoing biliopancreatic diversion","volume":"36","author":"Lugari","year":"2004","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.metabol.2008.11.009_bib16","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1038\/sj.ijo.0801655","article-title":"The role of postprandial releases of insulin and incretin hormones in meal-induced satiety\u2014effect of obesity and weight reduction","volume":"25","author":"Verdich","year":"2001","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.metabol.2008.11.009_bib17","first-page":"S240","article-title":"Separate impact of obesity and glucose tolerance on incretin effect in humans","volume":"50","author":"Muscelli","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2008.11.009_bib18","first-page":"774","article-title":"Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis","volume":"18","author":"Dunaif","year":"1997","journal-title":"Endocr Rev"},{"key":"10.1016\/j.metabol.2008.11.009_bib19","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.2337\/diab.38.9.1165","article-title":"Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome","volume":"38","author":"Dunaif","year":"1989","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2008.11.009_bib20","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11892-002-0061-y","article-title":"Insulin resistance and polycystic ovary syndrome","volume":"2","author":"Ehrmann","year":"2002","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.metabol.2008.11.009_bib21","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1385\/ENDO:30:1:13","article-title":"Insulin resistance in PCOS","volume":"30","author":"Diamanti-Kandarakis","year":"2006","journal-title":"Endocrine"},{"key":"10.1016\/j.metabol.2008.11.009_bib22","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.molmed.2006.05.006","article-title":"Molecular mechanisms of insulin resistance in polycystic ovary syndrome","volume":"12","author":"Diamanti-Kandarakis","year":"2006","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.metabol.2008.11.009_bib23","first-page":"66","article-title":"Glucose intolerance in obese adolescents with polycystic ovary syndrome: roles of insulin resistance and beta-cell dysfunction and risk of cardiovascular disease","volume":"86","author":"Arslanian","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2008.11.009_bib24","doi-asserted-by":"crossref","first-page":"4085","DOI":"10.1210\/jc.2002-021131","article-title":"Polycystic ovary syndrome, insulin resistance, and molecular defects of insulin signaling","volume":"87","author":"Azziz","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2008.11.009_bib25","doi-asserted-by":"crossref","first-page":"E1047","DOI":"10.1152\/ajpendo.00361.2004","article-title":"Insulin resistance in the skeletal muscle of women with PCOS involves intrinsic and acquired defects in insulin signaling","volume":"288","author":"Corbould","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"Suppl 1","key":"10.1016\/j.metabol.2008.11.009_bib26","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/j.fertnstert.2006.04.011","article-title":"Insulin resistance in women with polycystic ovary syndrome","volume":"86","author":"Dunaif","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.metabol.2008.11.009_bib27","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.2337\/diacare.24.6.1050","article-title":"Prevalence of polycystic ovary syndrome among premenopausal women with type 2 diabetes","volume":"24","author":"Peppard","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2008.11.009_bib28","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1210\/jc.2005-1329","article-title":"Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome","volume":"91","author":"Ehrmann","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2008.11.009_bib29","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1210\/jc.2004-1843","article-title":"Changes in glucose tolerance over time in women with polycystic ovary syndrome: a controlled study","volume":"90","author":"Legro","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2008.11.009_bib30","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1530\/EJE-08-0097","article-title":"Incretin levels in polycystic ovary syndrome","volume":"159","author":"Vrbikova","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.metabol.2008.11.009_bib31","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.metabol.2008.11.009_bib32","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1210\/jcem-21-11-1440","article-title":"Clinical assessment of body hair growth in women","volume":"21","author":"Ferriman","year":"1961","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2008.11.009_bib33","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1210\/jcem.84.10.6079","article-title":"A critical evaluation of simple methods for the estimation of free testosterone in serum","volume":"84","author":"Vermeulen","year":"1999","journal-title":"J Clinical Endocrinol Metab"},{"key":"10.1016\/j.metabol.2008.11.009_bib34","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1210\/jcem-56-6-1306","article-title":"Diminished immunoreactive gastric-inhibitory polypeptide response to a meal in newly diagnosed type 1 (insulin dependent) diabetics","volume":"56","author":"Krarup","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2008.11.009_bib35","doi-asserted-by":"crossref","first-page":"535","DOI":"10.2337\/diab.43.4.535","article-title":"Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans","volume":"43","author":"Orskov","year":"1994","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2008.11.009_bib36","first-page":"942","article-title":"Beta-cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome","volume":"81","author":"Dunaif","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2008.11.009_bib37","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.2337\/diabetes.54.7.2212","article-title":"Erythromycin antagonizes the deceleration of gastric emptying by glucagon-like peptide 1 and unmasks its insulinotropic effect in healthy subjects","volume":"54","author":"Meier","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2008.11.009_bib38","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/j.1471-0528.2006.00966.x","article-title":"The effect of metformin on fat distribution and the metabolic syndrome in women with polycystic ovary syndrome\u2014a randomised, double-blind, placebo-controlled trial","volume":"113","author":"Lord","year":"2006","journal-title":"BJOG"},{"key":"10.1016\/j.metabol.2008.11.009_bib39","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1210\/jc.2007-0441","article-title":"Insulin sensitivity after metformin suspension in normal-weight women with polycystic ovary syndrome","volume":"2","author":"Palomba","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2008.11.009_bib40","first-page":"139","article-title":"Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation","volume":"85","author":"Moghetti","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2008.11.009_bib41","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1210\/jcem.85.8.6738","article-title":"Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome","volume":"85","author":"Pasquali","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2008.11.009_bib42","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0006-291X(02)02565-2","article-title":"Enhanced secretion of glucagon-like peptide 1 by biguanide compounds","volume":"298","author":"Yasuda","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.metabol.2008.11.009_bib43","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.bbrc.2004.09.021","article-title":"Reduced serum dipeptidyl peptidase\u2013IV after metformin and pioglitazone treatments","volume":"324","author":"Lenhard","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.metabol.2008.11.009_bib44","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/j.1464-5491.2005.01461.x","article-title":"Inhibition of dipeptidyl peptidase IV activity by oral metformin in type 2 diabetes","volume":"22","author":"Lindsay","year":"2005","journal-title":"Diabet Med"},{"key":"10.1016\/j.metabol.2008.11.009_bib45","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ejphar.2006.07.043","article-title":"Inhibition of dipeptidyl peptidase\u2013IV activity by metformin enhances the antidiabetic effects of glucagon-like peptide\u20131","volume":"547","author":"Green","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.metabol.2008.11.009_bib46","first-page":"336","article-title":"Effects of metformin on glucagon-like peptide\u20131 levels in obese patients with and without type 2 diabetes","volume":"17","author":"Mannucci","year":"2004","journal-title":"Diabetes Nutr Metab"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049508004277?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049508004277?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T03:34:21Z","timestamp":1758425661000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049508004277"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":46,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["S0026049508004277"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2008.11.009","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incretin hormone secretion in women with polycystic ovary syndrome: roles of obesity, insulin sensitivity, and treatment with metformin","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2008.11.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}